Nayara.ai vs TrialClinIQ
Nayara.ai vs TrialClinIQ, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nayara.ai is on 54/100 and TrialClinIQ on 39/100.
Where each one leads
Nayara.ai
- our overall score: 54/100 against 39/100
- agent readiness: 44/100 against 31/100
- funding raised: $4.0M against $300K
TrialClinIQ
- domain rating: 29/100 against 10/100
At a glance
| Measure | Nayara.ai | TrialClinIQ |
|---|---|---|
| What it is | AI-driven clinical-grade breast cancer guide for women navigating their journey. | AI-powered clinical trial recruitment platform advancing health equity. |
| Category | HealthTech, MedTech, AI-Driven Drug Discovery, Clinical Trials | HealthTech, Biotechnology, Artificial Intelligence, Clinical Trials |
| Sells toBusiness model | B2C | B2B |
| Offering | Platform | Platform |
| Founded | 2023 | 2024 |
| Headquarters | San Francisco, United States | Houston, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Nayara.ai | TrialClinIQ |
|---|---|---|
| Employees | 12 | Not published |
| Total funding | $4.0M | $300K |
| Latest round | Not published | Pre-Seed |
| LinkedIn followers | 1,339 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nayara.ai | TrialClinIQ |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 39/100 |
| Traction | 44/100 | 27/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 46/100 | 16/100 |
| Quality | 58/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 10/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nayara.ai | TrialClinIQ |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CMS | Framer | Not detected |
| Frameworks | Not detected | Next.js, Tailwind CSS |
| Analytics | Google Tag Manager | Google Analytics 4 |
Product and pricing
| Measure | Nayara.ai | TrialClinIQ |
|---|---|---|
| Key features | Emotional Support, Physical Support, Logistics Support, HIPAA-compliant, Clinical-grade guide | Not published |
Nayara.ai vs TrialClinIQ: common questions
Which is better, Nayara.ai or TrialClinIQ?
On our 0-100 score Nayara.ai rates higher (54/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Nayara.ai and TrialClinIQ compare on the numbers?
Nayara.ai leads on our overall score (54/100 against 39/100), agent readiness (44/100 against 31/100), funding raised ($4.0M against $300K). TrialClinIQ leads on domain rating (29/100 against 10/100).
Read the full Nayara.ai review and pricing or the TrialClinIQ review and pricing. You can also browse other Nayara.ai alternatives we track.